Pharma Dar
Pharma Dar, officially known as Pharma Dar LLC, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 2010, the company has rapidly expanded its operations across North America and Europe, focusing on the development and distribution of high-quality generic and specialty pharmaceuticals. Pharma Dar is renowned for its commitment to innovation, offering a diverse portfolio of products that cater to various therapeutic areas, including oncology, cardiology, and infectious diseases. The company’s unique approach to quality assurance and regulatory compliance has positioned it as a trusted partner in the healthcare sector. With a strong market presence and a reputation for excellence, Pharma Dar continues to achieve significant milestones, contributing to improved patient outcomes and advancing healthcare solutions globally.
DitchCarbon Score
How does Pharma Dar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Dar's score of 18 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Dar's reported carbon emissions
Pharma Dar, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. In the pharmaceutical industry, companies are increasingly focusing on reducing their carbon footprints and committing to science-based targets to mitigate climate change. However, without concrete data or commitments from Pharma Dar, it remains unclear how they align with these industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Dar is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
